Geode Capital Management’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.8M Buy
828,743
+10,332
+1% +$135K ﹤0.01% 2314
2025
Q1
$12.2M Buy
818,411
+64,043
+8% +$954K ﹤0.01% 2168
2024
Q4
$13.7M Buy
754,368
+2,112
+0.3% +$38.4K ﹤0.01% 2163
2024
Q3
$10.1M Sell
752,256
-35,752
-5% -$481K ﹤0.01% 2367
2024
Q2
$10.9M Buy
788,008
+19,656
+3% +$272K ﹤0.01% 2270
2024
Q1
$14.4M Buy
768,352
+14,349
+2% +$269K ﹤0.01% 2108
2023
Q4
$17.1M Buy
754,003
+29,752
+4% +$674K ﹤0.01% 2010
2023
Q3
$18M Buy
724,251
+23,289
+3% +$577K ﹤0.01% 1889
2023
Q2
$19.7M Sell
700,962
-4,889
-0.7% -$137K ﹤0.01% 1866
2023
Q1
$15.8M Buy
705,851
+24,857
+4% +$555K ﹤0.01% 1958
2022
Q4
$18.1M Buy
680,994
+10,991
+2% +$292K ﹤0.01% 1837
2022
Q3
$19M Buy
670,003
+18,041
+3% +$512K ﹤0.01% 1769
2022
Q2
$13.6M Buy
651,962
+11,819
+2% +$246K ﹤0.01% 2037
2022
Q1
$13.9M Buy
640,143
+24,997
+4% +$542K ﹤0.01% 2130
2021
Q4
$17.1M Buy
615,146
+5,062
+0.8% +$141K ﹤0.01% 2063
2021
Q3
$13M Sell
610,084
-84
-0% -$1.78K ﹤0.01% 2271
2021
Q2
$10.1M Buy
610,168
+20,148
+3% +$333K ﹤0.01% 2452
2021
Q1
$7.37M Buy
590,020
+62,878
+12% +$785K ﹤0.01% 2568
2020
Q4
$4.68M Sell
527,142
-13,739
-3% -$122K ﹤0.01% 2640
2020
Q3
$3.51M Buy
540,881
+12,270
+2% +$79.6K ﹤0.01% 2587
2020
Q2
$3.26M Buy
528,611
+10,026
+2% +$61.7K ﹤0.01% 2560
2020
Q1
$3.5M Buy
518,585
+32,676
+7% +$220K ﹤0.01% 2356
2019
Q4
$5.65M Buy
485,909
+7,526
+2% +$87.4K ﹤0.01% 2379
2019
Q3
$4.93M Buy
478,383
+24,837
+5% +$256K ﹤0.01% 2391
2019
Q2
$4.25M Buy
453,546
+29,886
+7% +$280K ﹤0.01% 2501
2019
Q1
$2.98M Buy
423,660
+39,865
+10% +$280K ﹤0.01% 2614
2018
Q4
$2.81M Buy
383,795
+23,444
+7% +$172K ﹤0.01% 2566
2018
Q3
$3.15M Buy
360,351
+19,063
+6% +$166K ﹤0.01% 2649
2018
Q2
$3.84M Buy
341,288
+26,519
+8% +$298K ﹤0.01% 2483
2018
Q1
$3.5M Buy
314,769
+9,845
+3% +$109K ﹤0.01% 2465
2017
Q4
$3.89M Buy
304,924
+7,991
+3% +$102K ﹤0.01% 2353
2017
Q3
$4.23M Buy
296,933
+9,282
+3% +$132K ﹤0.01% 2304
2017
Q2
$3.71M Buy
287,651
+18,656
+7% +$241K ﹤0.01% 2351
2017
Q1
$3.86M Buy
268,995
+10,582
+4% +$152K ﹤0.01% 2264
2016
Q4
$4.03M Buy
258,413
+34,668
+15% +$541K ﹤0.01% 2197
2016
Q3
$2.64M Buy
223,745
+5,194
+2% +$61.2K ﹤0.01% 2390
2016
Q2
$3.04M Buy
218,551
+662
+0.3% +$9.21K ﹤0.01% 2210
2016
Q1
$2.53K Buy
217,889
+14,219
+7% +$165 ﹤0.01% 2294
2015
Q4
$3.34M Buy
203,670
+2,275
+1% +$37.3K ﹤0.01% 2148
2015
Q3
$2.74M Buy
201,395
+12,252
+6% +$167K ﹤0.01% 2226
2015
Q2
$2.4M Sell
189,143
-3,350
-2% -$42.5K ﹤0.01% 2381
2015
Q1
$2.28M Buy
192,493
+10,425
+6% +$124K ﹤0.01% 2356
2014
Q4
$2.27M Buy
182,068
+7,717
+4% +$96.3K ﹤0.01% 2346
2014
Q3
$1.62M Buy
174,351
+14,248
+9% +$132K ﹤0.01% 2485
2014
Q2
$1.04M Sell
160,103
-28,100
-15% -$183K ﹤0.01% 2775
2014
Q1
$1.52M Buy
188,203
+4,470
+2% +$36.1K ﹤0.01% 2513
2013
Q4
$1.83M Buy
183,733
+48,388
+36% +$483K ﹤0.01% 2348
2013
Q3
$820K Buy
135,345
+4,711
+4% +$28.5K ﹤0.01% 2702
2013
Q2
$674K Buy
+130,634
New +$674K ﹤0.01% 2700